Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Ptc Therapeutics Cmn (PTCT)

12.75 +0.17 (+1.35%)

5/25/2017  4:00pm

Open:

12.90

Pre. Close:

12.58

High:

12.98

Low:

12.52

Volume:

613,642

Market Cap:

437.53M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

13.13 - 13.68

13.68 - 14.11

Low:

11.98 - 12.21

12.21 - 12.39

Close:

12.39 - 13.03

13.03 - 13.52

Technical analysis  (as of: 2017-05-25 4:48:52 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 16.18     One year: 18.89

Support:

Support1: 11.87    Support2: 10.65

Resistance:

Resistance1: 13.85    Resistance2: 16.18

Pivot:

12.77

Moving Averages:

MA(5): 13.17     MA(20): 12.63

MA(100): 11.96     MA(250): 10.18

MACD:

MACD(12,26): 0.51     Signal(12,26,9): 0.57

%K %D:

%K(14,3): 71.67     %D(3): 79.92

RSI:

RSI(14): 54.89

52-Week:

High: 16.50  Low: 4.03  Change(%): 62.6

Average Vol(K):

3-Month: 1285  10-Days 624

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
PTCT has closed above bottom band by 49.2%. Bollinger Bands are 14.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 23 May 2017 12:00:00 GMT
New Analysis of ACT DMD Placebo Data on Corticosteroids Presented at ...

Wed, 07 Dec 2016 21:42:20 GMT
PTC Therapeutics, Inc. in 3 Charts

Thu, 16 Mar 2017 13:30:54 GMT
PTC Therapeutics will buy Marathon Pharma's controversial DMD drug for $75 mln ...

Mon, 08 May 2017 11:26:15 GMT
PTC Therapeutics Reports First Quarter 2017 Financial Results and Provides ...

Thu, 02 Mar 2017 17:03:45 GMT
Why PTC Therapeutics Is Plunging Today

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

33.00

% Held by Insiders

20.88

% Held by Institutions

97.10

Shares Short (K)

4770

Shares Short Prior Month (K)

4300

Stock Financials

EPS

-3.810

EPS Est. Current Year

-3.550

EPS Est. Next Year

-2.540

EPS Est. Next Quarter

-0.570

Forward EPS

Book Value (p.s.)

2.940

PEG Ratio

0.39

Profit Margin

-171.83

Operating Margin

-156.77

Return on Assets (ttm)

-25.5

Return on Equity (ttm)

-82.2

Qtrly Rev. Growth

97.8

Gross Profit (p.s.)

2.407

Sales Per Share

2.407

EBITDA (p.s.)

-3.678

Qtrly Earnings Growth

Operating Cash Flow (M)

-103.57

Levered Free Cash Flow (M)

-58.46

FoxReading.com

Valuation

P/E

-3.35

P/E Growth Ratio

0.01

P/BV

4.34

P/S

5.30

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.